GSK1521498 or placebo

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Obesity

Phase 1

A First-Time-In-Human Study in Healthy Subjects

CompletedNCT00857883

GlaxoSmithKlineObesity

Start: 2008-11-17End: 2009-08-01Updated: 2017-06-26

Effects of Repeat Dosing of GSK1521498

CompletedNCT00976105

GlaxoSmithKlineObesity

Start: 2009-09-22End: 2010-03-09Updated: 2017-06-20